A detailed history of Wellington Management Group LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 32,820,828 shares of BSX stock, worth $2.99 Billion. This represents 0.49% of its overall portfolio holdings.

Number of Shares
32,820,828
Previous 32,102,313 2.24%
Holding current value
$2.99 Billion
Previous $2.47 Billion 11.25%
% of portfolio
0.49%
Previous 0.45%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $52.4 Million - $60.4 Million
718,515 Added 2.24%
32,820,828 $2.75 Billion
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $79.9 Million - $92.2 Million
-1,186,504 Reduced 3.56%
32,102,313 $2.47 Billion
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $1.92 Billion - $2.28 Billion
33,288,817 New
33,288,817 $2.28 Billion
Q4 2023

Feb 12, 2024

BUY
$48.64 - $57.81 $1.77 Billion - $2.11 Billion
36,441,127 New
36,441,127 $2.11 Billion
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $117 Million - $128 Million
2,336,348 Added 5.88%
42,076,529 $2.22 Billion
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $336 Million - $369 Million
-6,761,474 Reduced 14.54%
39,740,181 $2.15 Billion
Q1 2023

May 12, 2023

SELL
$45.09 - $50.03 $507 Million - $562 Million
-11,234,685 Reduced 19.46%
46,501,655 $2.33 Billion
Q4 2022

Feb 13, 2023

SELL
$39.56 - $47.22 $190 Million - $227 Million
-4,800,659 Reduced 7.68%
57,736,340 $2.67 Billion
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $41.2 Million - $123 Million
-1,123,027 Reduced 1.76%
62,536,999 $2.42 Billion
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $165 Million - $220 Million
-4,679,386 Reduced 6.85%
63,660,026 $2.37 Billion
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $253 Million - $279 Million
-6,176,830 Reduced 8.29%
68,339,412 $3.03 Billion
Q4 2021

Feb 11, 2022

SELL
$38.07 - $44.87 $355 Million - $418 Million
-9,314,428 Reduced 11.11%
74,516,242 $3.17 Billion
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $211 Million - $235 Million
-5,123,566 Reduced 5.76%
83,830,670 $3.64 Billion
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $64.3 Million - $73.7 Million
-1,666,288 Reduced 1.84%
88,954,236 $3.8 Billion
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $471 Million - $530 Million
13,354,883 Added 17.28%
90,620,524 $3.5 Billion
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $619 Million - $783 Million
18,663,851 Added 31.85%
77,265,641 $2.78 Billion
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $92.6 Million - $114 Million
2,688,953 Added 4.81%
58,601,790 $2.24 Billion
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $400 Million - $519 Million
13,260,158 Added 31.09%
55,912,837 $1.96 Billion
Q1 2020

May 14, 2020

BUY
$25.83 - $45.71 $173 Million - $307 Million
6,714,969 Added 18.69%
42,652,679 $1.39 Billion
Q4 2019

Feb 11, 2020

BUY
$37.87 - $45.37 $1.36 Billion - $1.63 Billion
35,937,710 New
35,937,710 $1.63 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.